Skip to main content

01.12.2018 | Research article | Ausgabe 1/2018 Open Access

BMC Public Health 1/2018

Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study

BMC Public Health > Ausgabe 1/2018
Shishen Wang, Yuhui Tao, Yuchun Tao, Jing Jiang, Li Yan, Chong Wang, Yaxuan Ding, Jianxing Yu, Dinghui Zhao, Xiumei Chi, Xiaomei Wang, Ruihong Wu, Xiuzhu Gao, Ying Shi, Yazhe Guan, Yingchun Li, Yanli Xing, Haiyan Sun, Changhua Ta, Chao Wang, Junqi Niu, Jing Meng, Hongqin Xu
Wichtige Hinweise
Shishen Wang and Yuhui Tao contributed equally to this work.



Viral hepatitis, mainly hepatitis B and C, is a serious public health problem worldwide. In China, the prevalence of hepatitis B virus (HBV) infection remains high, while that of hepatitis C virus (HCV) infection is controversial. This study investigated the epidemiology of HBV and HCV infections and assessed the beneficial effect of the vaccination strategy for hepatitis B in Northeastern China.


From June 2016 to August 2016, 6541 residents of Changchun in Northeastern China were recruited for this cross-sectional study. Demographic characteristics as well as HBV and HCV serological test results were reviewed and analyzed.


Among all study participants, 3.8% and 0.36% tested positive for hepatitis B surface antigen (HBsAg) and anti-HCV, respectively. The HBsAg- and anti-HCV-positive rates were significantly higher in male participants (4.58% and 0.43%) than in female individuals (3.0% and 0.33%). Notably, among all age groups, the lowest rate of HBsAg positivity (0.2%) was found in children born after the implementation of the vaccination strategy for hepatitis B. Conversely, participants aged 40–49 years had significantly greater positive rates of HBsAg (5.9%) compared with those of other age groups. Furthermore, the highest rates of anti-HCV positivity (1.1%) were observed in participants aged 50–59 years.


The rate of HBsAg-positivity declined significantly following successful implementation of the policy on hepatitis B vaccination, indicating a beneficial impact on the control of HBV infection. However, only a slight decrease was observed in the anti-HCV–positivity rate, identifying an area in need of improvement within viral hepatitis prevention and control programs in China.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

BMC Public Health 1/2018 Zur Ausgabe